INTRODUCTION TO CLINICAL
PHARMACOLOGY TEST 10 COMPREHENSIVE
EXAM 2026 FULL QUESTIONS AND CORRECT
ANSWERS ALREADY PASSED
◉ Pregnancy and Lactation Labeling Rule (PLLR).
Answer: pregnancy exposure registry, risk summary, clinical
considerations, data
lactation information
females and males of reproductive potential
◉ pharmacogenomics.
Answer: study of how genetic (genome) differences in multiple
genes influence variability in drug response (efficacy and toxicity)
◉ pharmacogenetics.
Answer: study of how genetic differences in a single gene influence
variability in drug response (efficacy and toxicity)
◉ therapeutic index.
,Answer: margin of safety
TD50/ED50
a more dangerous drug has a lower therapeutic index
◉ agonist.
Answer: drug that combines with a receptor and produces the same
response as an endogenous chemical
stimulates the release of endogenous chemical
affinity and efficacy (intrinsic activity)
◉ antagonist (blocker).
Answer: a drug that combines with a receptor used by an
endogenous chemical and blocks or diminishes the response of the
endogenous agent
inhibits the release of endogenous agent
◉ partial agonist.
, Answer: affinity but low efficacy
◉ competitive antagonism.
Answer: agonist and antagonist compete for same receptor site
◉ irreversible antagonist.
Answer: covalent or tight bonds with D and R so R is unavailable and
inaccessible to agonist
◉ non-competitive antagonism.
Answer: agonist and antagonist bind at different sites on the same
receptor
◉ dose v. response.
Answer: amount v. effect on body
◉ potency.
Answer: drug A is said to be more potent than drug B if the dose of A
is less than B to achieve the same response
relates to affinity
PHARMACOLOGY TEST 10 COMPREHENSIVE
EXAM 2026 FULL QUESTIONS AND CORRECT
ANSWERS ALREADY PASSED
◉ Pregnancy and Lactation Labeling Rule (PLLR).
Answer: pregnancy exposure registry, risk summary, clinical
considerations, data
lactation information
females and males of reproductive potential
◉ pharmacogenomics.
Answer: study of how genetic (genome) differences in multiple
genes influence variability in drug response (efficacy and toxicity)
◉ pharmacogenetics.
Answer: study of how genetic differences in a single gene influence
variability in drug response (efficacy and toxicity)
◉ therapeutic index.
,Answer: margin of safety
TD50/ED50
a more dangerous drug has a lower therapeutic index
◉ agonist.
Answer: drug that combines with a receptor and produces the same
response as an endogenous chemical
stimulates the release of endogenous chemical
affinity and efficacy (intrinsic activity)
◉ antagonist (blocker).
Answer: a drug that combines with a receptor used by an
endogenous chemical and blocks or diminishes the response of the
endogenous agent
inhibits the release of endogenous agent
◉ partial agonist.
, Answer: affinity but low efficacy
◉ competitive antagonism.
Answer: agonist and antagonist compete for same receptor site
◉ irreversible antagonist.
Answer: covalent or tight bonds with D and R so R is unavailable and
inaccessible to agonist
◉ non-competitive antagonism.
Answer: agonist and antagonist bind at different sites on the same
receptor
◉ dose v. response.
Answer: amount v. effect on body
◉ potency.
Answer: drug A is said to be more potent than drug B if the dose of A
is less than B to achieve the same response
relates to affinity
